ScholarLens Back to search
2008•Chinese Journal of Clinical OncologyRequires access

Clinical implications of HER-2 and P53 in taxane-based and anthracycline-based neoadjuvant chemotherapy in breast cancer

Xiaolan Wang, Fan Yao, Nan Liu, Yunfei Wu, Xinyu Zheng, Jiguang Li, Caigang Liu, Xueshan Qiu, Feng Jin

Open publisher page 0 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Anthracycline, Taxane, Chemotherapy, Breast cancer, Internal medicine, Medicine, Oncology, Cancer

Related papers

Related paper 1Related paper 2
Back to paper searchBrowse research topicsOriginal source
Clinical implications of HER-2 and P53 in taxane-based and anthracycline-based neoadjuvant chemotherapy in breast cancer — Research Paper | ScholarLens